Labiriad (Aciclovir)

Aciclovir is a nucleoside analogue that, after activation by viral thymidine kinase, becomes aciclovir triphosphate. This metabolite inhibits viral DNA polymerase, halting DNA chain elongation and preventing replication of the herpes simplex virus at the site of application.

The specific dosing regimen for Labiriad is determined by the prescribing healthcare professional based on the infection type, severity, and patient factors. Patients should follow the prescriber’s instructions and not alter the dosage without medical advice.

Safety data for topical aciclovir during pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any risks before prescribing Labiriad to pregnant or nursing individuals.

To request Labiriad, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Labiriad’s active ingredient, aciclovir, is a first‑line antiviral for herpes simplex infections. Compared with newer agents such as valacyclovir, aciclovir has a well‑established safety profile but may require more frequent application. Choice of therapy depends on clinical judgment, patient preference and cost considerations.

Store Labiriad at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Ensure the container is tightly closed to maintain product stability and prevent contamination.

Labiriad is applied topically to the affected gingival area. The prescribed amount is spread gently over the lesion using a clean applicator or fingertip, following the healthcare provider’s instructions regarding frequency and duration of treatment.

Serious adverse reactions, although rare, include severe allergic responses such as rash, urticaria, angioedema, Stevens‑Johnson syndrome, and anaphylaxis. Systemic toxicity like nephrotoxicity may occur with excessive absorption, especially in patients with renal impairment.

Labiriad should be avoided in individuals with a known hypersensitivity to aciclovir or any component of the formulation. Patients with severe renal dysfunction should use it only under medical supervision, and pregnant or breastfeeding women should consult their clinician before use.